SCHEMBL24946314

SCHEMBL24946314

CC(C)c1cc(Cl)c(C(F)(F)F)cc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.56
GABRA1 P14867 2/20 0.39
GABRB1 P18505 1/20 0.39
PDE2A O00408 1/20 0.39
TRPA1 O75762 1/20 0.37
CHRM1 P11229 1/20 0.37
SLC6A2 P23975 1/20 0.37
ADRA1A P35348 1/20 0.37
HTR2B P41595 1/20 0.37
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
KDM4E B2RXH2 1/20 0.35
P2RX7 Q99572 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HTR3E A5X5Y0 1/20 0.34
HTR3B O95264 1/20 0.34
HTR3A P46098 1/20 0.34
HTR3D Q70Z44 1/20 0.34
HTR3C Q8WXA8 1/20 0.34
KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26769516 0.93 LMNA (0.52) LMNAGABRA1GABRB1PDE2ATRPA1
SCHEMBL16745686 0.83 LMNA (0.58) LMNAGABRA1GABRB1TRPA1CHRM1
SCHEMBL15256022 0.82 LMNA (0.47) LMNAGABRA1GABRB1TRPA1CHRM1
SCHEMBL18262832 0.79 LMNA (0.42) LMNAGABRA1GABRB1TRPA1CHRM1
SCHEMBL12303919 0.79 PDE2A (0.42) LMNAGABRA1GABRB1PDE2AKDM4E
SCHEMBL16736892 0.78 LMNA (0.47) LMNAGABRA1GABRB1PDE2ATRPA1
SCHEMBL10702604 0.78 LMNA (0.72) LMNAGABRA1GABRB1TRPA1CHRM1
SCHEMBL22984901 0.76 LMNA (0.39) LMNAGABRA1GABRB1PDE2ATRPA1
SCHEMBL21686455 0.76 LMNA (0.69) LMNAGABRA1GABRB1TRPA1CHRM1
SCHEMBL16736820 0.76 LMNA (0.69) LMNAGABRA1GABRB1TRPA1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230373952-A1 LACTAM COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-11-23 US disclosed
US-20230373952-A1 LACTAM COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-11-23 US disclosed
US-20230026611-A1 ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026611-A1 ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS KCNA3, KCNH2, KCNJ2 LMNA 2534/4885GABRA1 235/4885GABRB1 184/4885
US-20230373952-A1 LACTAM COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS KCNK3, KCNA3, KCNJ2 LMNA 2352/4885GABRA1 396/4885GABRB1 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.